These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11669305)

  • 21. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
    Latifzadeh SZ; Entezari V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
    Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
    Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.
    Shvidel L; Klepfish A; Berrebi A
    Am J Hematol; 2001 Jul; 67(3):213-4. PubMed ID: 11391724
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
    Torii Y; Yagasaki H; Tanaka H; Mizuno S; Nishio N; Muramatsu H; Hama A; Takahashi Y; Kojima S
    Int J Hematol; 2009 Sep; 90(2):174-176. PubMed ID: 19662467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.
    Goto S; Goto H; Tanoshima R; Kato H; Takahashi H; Sekiguchi O; Kai S
    Int J Hematol; 2009 Apr; 89(3):305-309. PubMed ID: 19308659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S; Asher I; Sthoeger Z
    Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab in autoimmune hematologic diseases: not just a matter of B cells.
    Stasi R
    Semin Hematol; 2010 Apr; 47(2):170-9. PubMed ID: 20350664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of a patient with mixed warm and cold antibody mediated Evans syndrome and glucose intolerance.
    Jubinsky PT; Rashid N
    Pediatr Blood Cancer; 2005 Sep; 45(3):347-50. PubMed ID: 15704210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.
    Rückert A; Glimm H; Lübbert M; Grüllich C
    Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab in the treatment of autoimmune haematological disorders.
    Garvey B
    Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.
    Riksen NP; Keuning JJ; Vreugdenhil G
    Neth J Med; 2003 Jul; 61(7):262-5. PubMed ID: 14567524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura.
    Bengtson KL; Skinner MA; Ware RE
    J Pediatr; 2003 Nov; 143(5):670-3. PubMed ID: 14615744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M; Trimis G; Pergantou H; Platokouki H; Vrachnou E; Tzortzatou-Stathopoulou F
    J Paediatr Child Health; 2005 Jul; 41(7):384-6. PubMed ID: 16014149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.
    Faurschou M; Hasselbalch HC; Nielsen OJ
    Eur J Haematol; 2001 Jun; 66(6):408-11. PubMed ID: 11488941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus.
    ten Cate R; Smiers FJ; Bredius RG; Lankester AC; van Suijlekom-Smit LW; Huizinga TW; Egeler RM
    Rheumatology (Oxford); 2004 Feb; 43(2):244. PubMed ID: 14739467
    [No Abstract]   [Full Text] [Related]  

  • 37. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
    Willis F; Marsh JC; Bevan DH; Killick SB; Lucas G; Griffiths R; Ouwehand W; Hale G; Waldmann H; Gordon-Smith EC
    Br J Haematol; 2001 Sep; 114(4):891-8. PubMed ID: 11564082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
    Giagounidis AA; Anhuf J; Schneider P; Germing U; Söhngen D; Quabeck K; Aul C
    Eur J Haematol; 2002 Aug; 69(2):95-100. PubMed ID: 12366712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy in a patient with severe multiple systemic autoimmune disease.
    Tamai Y; Takami H; Akagi T; Kawamura S; Munakata A
    Clin Lab Haematol; 1998 Oct; 20(5):315-6. PubMed ID: 9807680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.